[ESPR] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -26.11%
YoY- -37.00%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 18,980 14,409 3,833 981 0 0 0 -
PBT -55,117 -69,386 -85,437 -68,377 -49,911 -45,219 -17,402 21.17%
Tax 13,494 13,667 4,970 5,383 0 606 488 73.85%
NP -68,611 -69,386 -85,437 -68,377 -49,911 -45,219 -17,402 25.67%
Tax Rate - - - - - - - -
Total Cost 87,591 83,795 89,270 69,358 49,911 45,219 17,402 30.89%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -361.49 -481.55 -2,228.99 -6,970.13 0.00 0.00 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -1.01 -2.62 -3.07 -2.52 -1.86 -1.86 -0.77 4.62%
EPS Diluted -1.01 -2.62 -3.07 -2.52 -1.86 -1.86 -0.77 4.62%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.